Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03648359 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Multiparametric MRI in Men With Prostate Cancer Enrolled in Active Surveillance

StatusEnrolling by Invitation
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 1 year 10 months later Jan 2026 → Dec 2027
See other at-risk trials from Herlev Hospital

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion pushed from Jan 2026 to Dec 2027
    • Eligibility criteria expanded, about 12 words
  2. Re-verified, no change to tracked fieldsv9
  3. Primary and study completion dates: Jan 2024 to Jan 2026v8
  4. Re-verified, no change to tracked fieldsv7
  5. Primary and study completion dates: Jan 2022 to Jan 2024v6
Show 4 earlier versionsHide 4 earlier versions
  1. Trial status: Not Yet Recruiting to Enrolling by Invitation
    • Primary and study completion dates: Jan 2021 to Jan 2022
    • Start date changed from estimate of May 2020 to May 1, 2020
    v5
  2. Primary and study completion dates: Jan 2020 to Jan 2021
    • Start date: Sep 2019 to May 2020
    v4
  3. Start date: Apr 2019 to Sep 2019v3
  4. Start date: Sep 2018 to Apr 2019
    • Study sites: 0 to 1
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Herlev Hospital
27 trials monitored
See 3 trials at risk
Prostate Cancer
2,546 trials monitored
See 172 trials at risk
To investigate whether multiparametric MRI (mp-MRI) in patients with low-risk prostate cancer can improve the selection of patients suitable for Active Surveillance and have a relevance in the ongoing monitoring
Trial Details
NCT Number NCT03648359
Lead Sponsor Herlev Hospital
Conditions
(from sponsor)		 Prostatic Neoplasms
Related terms Prostatic Neoplasms
Enrollment 200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov